Tuberculosis: Current Treatment, Diagnostics, and Newer Antitubercular Agents in Clinical Trials

E-ISSN： 2212-3989|15|1|32-41

ISSN： 1871-5265

Source： Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol.15, Iss.1, 2015-03, pp. : 32-41

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Acute Severe Hypertension: Current and Newer Agents

By Varon Joseph

Drugs, Vol. 68, Iss. 3, 2008-01 ,pp. : 283-297

Adis International

Access to resources Recommend Favorite

Current treatment and clinical trials in ovarian cancer

By Han Liz Y Kipps Emma Kaye Stan B

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 4, 2010-04 ,pp. : 521-534

Informa Healthcare

Access to resources Recommend Favorite

Human Tuberculosis. III. Current and Prospective Approaches in Anti-Tubercular Therapy

Current Medicinal Chemistry, Vol. 23, Iss. 21, 2016-08 ,pp. : 2245-2274

Bentham Science Publishers

Access to resources Recommend Favorite

Antimycobacterial drugs currently in Phase II clinical trials and preclinical phase for tuberculosis treatment

By Engohang-Ndong Jean

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 12, 2012-12 ,pp. : 1789-1800

Informa Healthcare

Access to resources Recommend Favorite

Phenothiazines as anti-tubercular agents: mechanistic insights and clinical implications

By Sharma Sadhna Singh Amandeep

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 12, 2011-12 ,pp. : 1665-1676

Informa Healthcare

Access to resources Recommend Favorite